Lambertini, Matteo http://orcid.org/0000-0003-1797-5296
Ceppi, Marcello
Hamy, Anne-Sophie http://orcid.org/0000-0003-4430-3022
Caron, Olivier http://orcid.org/0000-0001-8934-2071
Poorvu, Philip D.
Carrasco, Estela
Grinshpun, Albert http://orcid.org/0000-0002-3351-5719
Punie, Kevin http://orcid.org/0000-0002-1162-7963
Rousset-Jablonski, Christine http://orcid.org/0000-0001-7087-5687
Ferrari, Alberta http://orcid.org/0000-0003-2525-3787
Paluch-Shimon, Shani
Toss, Angela
Senechal, Claire
Puglisi, Fabio http://orcid.org/0000-0003-0573-4938
Pogoda, Katarzyna
Pérez-Fidalgo, Jose Alejandro
De Marchis, Laura
Ponzone, Riccardo http://orcid.org/0000-0002-8822-2454
Livraghi, Luca http://orcid.org/0000-0002-9119-6277
Estevez-Diz, Maria Del Pilar http://orcid.org/0000-0003-3176-9747
Villarreal-Garza, Cynthia http://orcid.org/0000-0003-3587-339X
Dieci, Maria Vittoria http://orcid.org/0000-0002-3967-9861
Clatot, Florian
Duhoux, Francois P. http://orcid.org/0000-0002-5429-7888
Graffeo, Rossella
Teixeira, Luis
Córdoba, Octavi http://orcid.org/0000-0002-9591-7430
Sonnenblick, Amir
Ferreira, Arlindo R.
Partridge, Ann H. http://orcid.org/0000-0002-4722-4824
Di Meglio, Antonio
Saule, Claire
Peccatori, Fedro A. http://orcid.org/0000-0001-8227-8740
Bruzzone, Marco http://orcid.org/0000-0002-8821-4542
t’Kint de Roodenbeke, Marie Daphne
Ameye, Lieveke
Balmaña, Judith http://orcid.org/0000-0002-0762-6415
Del Mastro, Lucia http://orcid.org/0000-0002-9546-5841
Azim, Hatem A. Jr.
Article History
Received: 15 September 2020
Accepted: 7 January 2021
First Online: 12 February 2021
Competing interests
: M.L. acted as a consultant for Roche, AstraZeneca, Lilly and Novartis, and received honoraria from Sandoz, Roche, Novartis, Takeda, Pfizer and Lilly outside the submitted work. O.C. acted as a consultant for AstraZeneca, and received travel grants from Ipsen outside the submitted work. C.R.J. acted as a consultant for Mylan medical, and received honoraria from Theramex and Bayer outside the submitted work. F.P. acted as a consultant for Astrazeneca, Daichii Sankyo, MSD, Novartis, Pierre Fabre, and Roche, received honoraria from Lilly, Novartis, Pfizer, Roche and Takeda, and received research grants from Astrazeneca, EISAI, and Roche outside the submitted work. K.P. acted as a consultant, received speaker honoraria and travel grants from Roche, Novartis, Pfizer, AstraZeneca, Lilly, Pierre Fabre, Egis, Amgen, Angelini and Teva outside the submitted work. J.A.P.F. acted as a consultant for Amgem, Astrazeneca, Clovis, and G.S.K., received honoraria from Roche, Astrazeneca, Novartis, Clovis, and G.S.K. and travel expenses by Roche, Astrazeneca, Pfizer, and G.S.K. outside the submitted work. C.V.G. acted as a consultant for Pfizer, Roche, Novartis, and Lilly, received honoraria from Myriad Genetics, Roche and Novartis, research funding from Roche and AstraZeneca, and travel expenses by Roche, MSD Oncology and Pfizer outside the submitted work. F.C. acted as a consultant for Lilly, BMS and Roche, received speaker honoraria from Merck Serono and BMS, research funding to his institution from AstraZeneca, and travel grants from Roche, Merck Serono, and BMS outside the submitted work. F.P.D. acted as a consultant for Roche, Pfizer, AstraZeneca, Lilly, Amgen, Novartis, Pierre Fabre, and Daiichi Sankyo, and received travel grants from Roche, Pfizer, Teva, and Amgen outside the submitted work. L.T. acted as a consultant for AstraZeneca, Lilly, Novartis, Pfizer, and Roche, received speaker honoraria from AstraZeneca, Merck Serono, Lilly, Novartis, Roche, research funding to his institution from Pfizer and Novartis, and travel grants from Roche, Merck Serono, and AstraZeneca, Novartis and Roche outside the submitted work. A.S. acted as a consultant for Novartis, Roche, Pfizer, and Lilly, received speaker honoraria from Roche, Pfizer, Medison, Lilly, and Novartis, research funding from Novartis, and travel grants from Medison and Roche outside the submitted work. A.R.F. received travel grants from Novartis and Roche outside the submitted work. A.D.M. received honoraria from ThermoFisher outside of the submitted work. J.B. acted as a consultant and received travel grants from Pfizer and Astra Zeneca outside the submitted work. L.D.M. acted as a consultant for Roche, Novartis, MSD, Pfizer, Ipsen, AstraZeneca, Genomic Health, Lilly, Seattle Genetics, Eisai, Pierre Fabre, and Daiichi Sankyo, received speaker honoraria from Roche, Novartis, Lilly and MSD, and travel grants from Roche, Pfizer and Celgene outside the submitted work. H.A.A. Jr acted as a consultant for Roche, received honoraria from Novartis outside the submitted work, and reported employment at Innate Pharma at the end of this study; this employment is not related in any sort to the subject of the current study. All the other authors declare no competing interests.